4.5 Article

Intestinal microbiota and overweight

Journal

BENEFICIAL MICROBES
Volume 1, Issue 4, Pages 407-421

Publisher

WAGENINGEN ACADEMIC PUBLISHERS
DOI: 10.3920/BM2010.0030

Keywords

obesity; intestinal bacteria; metabolic syndrome; type II diabetes; probiotics

Ask authors/readers for more resources

The microbes in our gut can influence our weight by providing us with energy through the degradation of nondigestable carbohydrates and by affecting the cellular energy status of liver and muscle cells and the accumulation of lipids in adipose tissue. Thus, it is not surprising that in several studies the gastrointestinal microbiota of overweight and obese subjects has been found to differ from that of lean subjects. The initial findings linked obesity with proportionally decreased levels of the phylum Bacteroidetes and increased levels of the phylum Firmicutes. Later, several studies have assessed the association between overweight or obesity and the gastrointestinal microbiota, applying an array of molecular methods targeting the microbiota as a whole or specific bacterial groups or species within. However, at present it is difficult to draw conclusions on which of the observed microbiota alterations are relevant; essentially all of the bacterial groups that have been studied in more than one trial have given contradictory results in regard to their association with weight. Some of these discrepancies can result from methodological issues and some from the nature of the gastrointestinal microbiota, which is an extremely complex and dynamic microbial ecosystem with high subject specificity. In addition, selecting subjects purely based on weight may result in a largely heterogeneous group with several potentially confounding factors. While it may be premature to conclude which specific groups of bacteria are prominent in the intestinal tract of overweight and obese subjects, it appears clear that microbes contribute to weight gain and related health issues, such as the metabolic syndrome and type II diabetes. Therefore, it is important to continue to search for common microbial markers and predictors of obesity, and to study how these may be modulated with probiotics and prebiotics to promote health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage

Sofia Forssten, Arthur C. Ouwehand

MICROORGANISMS (2020)

Review Nutrition & Dietetics

Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research

Henna-Maria Uusitupa, Pia Rasinkangas, Markus J. Lehtinen, Sanna M. Makela, Kaisa Airaksinen, Heli Anglenius, Arthur C. Ouwehand, Johanna Maukonen

NUTRIENTS (2020)

Article Food Science & Technology

Technological Characterisation of Probiotic Lactic Acid Bacteria as Starter Cultures for Dry Fermented Sausages

Nadia de L. Aguero, Laureano S. Frizzo, Arthur C. Ouwehand, Gonzalo Aleu, Marcelo R. Rosmini

FOODS (2020)

Article Microbiology

Recovery of Vaginal Microbiota after Standard Treatment for Bacterial Vaginosis Infection: An Observational Study

Liisa Lehtoranta, Ashley A. Hibberd, Jenni Reimari, Jouni Junnila, Nicolas Yeung, Johanna Maukonen, Gordon Crawford, Arthur C. Ouwehand

MICROORGANISMS (2020)

Article Chemistry, Multidisciplinary

Effects of Colonic Fermentation Products of Polydextrose, Lactitol and Xylitol on Intestinal Barrier Repair In Vitro

Yuan Yue, Ditte S. G. Nielsen, Sofia D. Forssten, Knud Erik B. Knudsen, Markku T. Saarinen, Arthur C. Ouwehand, Stig Purup

Summary: The study investigated the effects of fermentation products of polydextrose, lactitol, and xylitol on impaired colonic epithelial barrier function. It was found that xylitol fermentation products exhibited better repairing effects than that of polydextrose and lactitol, mainly due to the high production of butyrate. This suggests that functional food ingredients that mainly produce butyrate during fermentation may be more beneficial for improving gut health related to chronic diseases.

APPLIED SCIENCES-BASEL (2021)

Article Microbiology

Regulation of hBD-2, hBD-3, hCAP18/LL37, and Proinflammatory Cytokine Secretion by Human Milk Oligosaccharides in an Organotypic Oral Mucosal Model

Ulvi K. Gursoy, Krista Salli, Eva Soderling, Mervi Gursoy, Johanna Hirvonen, Arthur C. Ouwehand

Summary: The study found that 3-FL alone or in combination with 2'-FL can stimulate oral mucosal secretion of hBD-2 without inducing a proinflammatory response.

PATHOGENS (2021)

Article Nutrition & Dietetics

Evaluation of 2'-Fucosyllactose and Bifidobacterium longum Subspecies infantis on Growth, Organ Weights, and Intestinal Development of Piglets

Victoria C. Daniels, Marcia H. Monaco, Mei Wang, Johanna Hirvonen, Henrik Max Jensen, Arthur C. Ouwehand, Ratna Mukherjea, Ryan N. Dilger, Sharon M. Donovan

Summary: This study investigated the effects of supplementing piglet formula with 2'-fucosyllactose (2'-FL) and Bifidobacterium longum subsp. infantis Bi-26 (Bi-26) on piglet growth and intestinal development. The results showed that the addition of 2'-FL and/or Bi-26 supported piglet growth without detrimental effects on body weight, organ weight, or intestinal structure and function.

NUTRIENTS (2022)

Article Nutrition & Dietetics

One Giant Leap from Mouse to Man: The Microbiota-Gut-Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials

Sofia D. Forssten, Arthur C. Ouwehand, Sile M. Griffin, Elaine Patterson

Summary: The microbiota-gut-brain axis is a bidirectional communication pathway between the gut microbiota and the brain that influences brain physiology, function, and behavior. Probiotics have been shown to improve health by altering the gut environment and evidence suggests their beneficial effects on mental and brain health. This review focuses on the role of probiotics and the microbiota-gut-brain axis in mood disorders and explores the challenges in translating preclinical research into clinical research.

NUTRIENTS (2022)

Review Nutrition & Dietetics

Role of D-mannose in urinary tract infections - a narrative review

Reeta Ala-Jaakkola, Arja Laitila, Arthur C. Ouwehand, Liisa Lehtoranta

Summary: Urinary tract infections (UTIs) are a common bacterial disease worldwide, and antibiotic resistance is a major concern. D-mannose, a dietary supplement, shows promise as an alternative treatment for UTIs, reducing the risk and recurrence.

NUTRITION JOURNAL (2022)

Article Microbiology

In Vitro Screen of Lactobacilli Strains for Gastrointestinal and Vaginal Benefits

Heli Anglenius, Harri Makivuokko, Ilmari Ahonen, Sofia D. D. Forssten, Pirjo Wacklin, Jaana Matto, Sampo Lahtinen, Liisa Lehtoranta, Arthur C. C. Ouwehand

Summary: In this study, 100 commercial and non-commercial strains of lactobacilli were tested for their suitability for gastrointestinal or vaginal applications. The study found that commercial strains grew better than newly isolated strains, but all strains showed tolerance to acid. Tolerance to bile varied between strains, and VEC adhesion and H2O2 production were species- and strain-specific.

MICROORGANISMS (2023)

Article Gastroenterology & Hepatology

Emerging issues in probiotic safety: 2023 perspectives

Daniel Merenstein, Bruno Pot, Gregory Leyer, Arthur C. Ouwehand, Geoffrey A. Preidis, Christopher A. Elkins, Colin Hill, Zachery T. Lewis, Andrea L. Shane, Niv Zmora, Mariya I. Petrova, Maria Carmen Collado, Lorenzo Morelli, Gina A. Montoya, Hania Szajewska, Daniel J. Tancredi, Mary Ellen Sanders

Summary: Probiotics are used by both healthy individuals and in clinical settings, but there are potential risks associated with their consumption. This has led to the need for concise recommendations on how to ensure the safe and effective use of new probiotic strains and products, especially in vulnerable populations.

GUT MICROBES (2023)

Article Microbiology

The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites

Krista Salli, Johanna Hirvonen, Heli Anglenius, Ashley A. A. Hibberd, Ilmari Ahonen, Markku T. T. Saarinen, Johanna Maukonen, Arthur C. C. Ouwehand

Summary: In this study, the effects of human milk oligosaccharides (HMOs) on infant faecal microbiota and microbial metabolites were evaluated using a semi-continuous colon simulator. The results showed that HMOs decreased diversity and increased the abundance of Bifidobacterium species, which correlated with the production of microbial metabolites. These findings suggest that HMOs and probiotics have benefits for the developing infant gut microbiota.

MICROORGANISMS (2023)

Article Biochemistry & Molecular Biology

Dynamics of the Lipidome in a Colon Simulator

Matilda Krakstrom, Alex M. Dickens, Marina Amaral Alves, Sofia D. Forssten, Arthur C. Ouwehand, Tuulia Hyotylainen, Matej Oresic, Santosh Lamichhane

Summary: Current evidence suggests that gut microbiome-derived lipids play a crucial role in regulating host lipid metabolism. This study used targeted and untargeted lipidomics to analyze in vitro-derived feces and found that the lipid profiles of the simulated intestinal chyme were influenced by the vessel and time. Various types of lipids, including phosphatidylcholines, sphingomyelins, triacylglycerols, and endocannabinoids, were found to be altered in different compartments of the human colon model over time.

METABOLITES (2023)

Article Nutrition & Dietetics

The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion

Nicolas Yeung, Sofia D. Forssten, Markku T. Saarinen, Mehreen Anjum, Arthur C. Ouwehand

Summary: This study investigated the impact of different food matrices on the delivery of HN019 probiotic via simulated human digestion. The results showed that HN019 could be detected from all tested matrices, including frozen culture, freeze-dried powder, and various food matrices. The observed changes in metabolite profile were consistent with the food matrix used. Hence, this study suggests that the food matrix supplemented with HN019 does not interfere with probiotic delivery to the colon via simulated human digestion.

NUTRIENTS (2023)

Article Biochemistry & Molecular Biology

Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment

Sofia D. Forssten, Nicolas Yeung, Arthur C. Ouwehand

BIOMEDICINES (2020)

No Data Available